Anaxago Group
Finance · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
18 Rue Sainte-foy, Paris, Ile-de-France,...Phone Number
+33 184174176Website
www.anaxago.comRevenue
$26.3 MillionIndustry
About Anaxago Group
Is Anaxago Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Anaxago Group had a recent Job posting/layoffs
Anaxago Group, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Anaxago Group has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Anaxago Group recently announced quarterly report
Check out if Anaxago Group is spiking on competitors!
Check if Anaxago Group has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Anaxago Group launches new products
Congratulate Masked Content for being promoted to Masked Content at Anaxago Group
Recommended Actions
Reach out to Masked Content who joined Anaxago Group as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Anaxago Group is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Anaxago Group is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Anaxago Group.
Anaxago Group Tech Stack
A closer look at the technologies used by Anaxago Group
Most Recent Scoops
Anaxago Group News & Media
PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical development of its lead candidate PEP-010
Additional funding comprises €1.6 million in equity as well as a €1 million loan from Bpifrance PARIS, July 19, 2021 /PRNewswire/ -- PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies for the treatment of cancers, announced today that it raised...PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical ...
/PRNewswire/ -- PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies for the treatment of cancers, announced today...IMAGEENS Raises 1.2Mn€ Seed Financing Round to Launch Its First Two Products
PARIS--(BUSINESS WIRE)--IMAGEENS, a Paris-based medical Artificial Intelligence (AI) startup developing software solutions for the analysis of medical images, has secured 1.2Mn€ in seed financing. The round was led by Anaxago, with a participation from BADGE (Business Angels des Grandes Ecoles), COALESCENCE, and existing IMAGEENS investors. IMAGEENS' software solutions allow radiologists, cardiologists and vascular surgeons to make personalized decisions and to better assess the cardiovascularAnaxago Moves Neo-Private Bank Strategy Forward by Launching a Green Bond
Founded in 2012 in France as an equity crowdfunding platform, the Anaxago group powers on with carrying out its strategy to be the first 100% digital neo-private bank. The group aims to give to the greater number access to financial products combining impact and performance.... Read More The post Anaxago Moves Neo-Private Bank Strategy Forward by Launching a Green Bond appeared first on Crowdfund Insider.
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Anaxago Group
Anaxago is a leading crowdfunding platform specializing in real estate investment and innovation, offering investors access to unique opportunities in private equity and real estate. Established in 2012, it has supported over 15,000 investors in diversifying their financial portfolios with targeted returns ranging from 7% to 14%. The company emphas... Read More